Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 52351-52400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06546865
Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) vs 26 F Sheath HoLEP for BPH: RCT
NA
Recruiting
142 participants
Started: Apr 16, 2024 · Completed: Apr 16, 2025
1 condition
1 sponsor
1 location
NCT06467097
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
PHASE3
Recruiting
88 participants
Started: Apr 16, 2024 · Completed: Feb 13, 2031
1 condition
1 sponsor
1 location
NCT06422286
Efficacy of Low-level Laser Acupuncture and Microcurrent Electrical Stimulation on Gag Reflex on Children
NA
Recruiting
63 participants
Started: Apr 16, 2024 · Completed: Dec 16, 2024
1 condition
1 sponsor
1 location
NCT06311773
Pivotal Trial of the Boomerang Catheter for pDVA
NA
Enrolling by invitation
120 participants
Started: Apr 16, 2024 · Completed: Mar 31, 2029
1 condition
1 sponsor
16 locations
NCT05950997
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
NA
Recruiting
89 participants
Started: Apr 16, 2024 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06258993
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
NA
Recruiting
85 participants
Started: Apr 16, 2024 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT06365502
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
NA
Recruiting
1,860 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2030
1 condition
2 sponsors
18 locations
NCT06267482
Using ROSA for Challenging The TKA Standard of Care
PHASE4
Recruiting
90 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06406660
Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer
NA
Recruiting
20 participants
Started: Apr 16, 2024 · Completed: Jun 16, 2026
1 condition
2 sponsors
1 location
NCT06422273
Protest Trial: TXA vs Saline
PHASE3
Enrolling by invitation
94 participants
Started: Apr 16, 2024 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06144177
Induction in the Dark
PHASE4
Recruiting
240 participants
Started: Apr 16, 2024 · Completed: Jun 22, 2026
1 condition
1 sponsor
1 location
NCT06673225
INSPIRE Respiratory Health Program in Botucatu, São Paulo, Brazil
N/A
Recruiting
2,000 participants
Started: Apr 16, 2024 · Completed: Dec 1, 2029
3 conditions
2 sponsors
1 location
NCT06364696
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
PHASE1
Recruiting
175 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
7 locations
NCT06292117
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
N/A
Recruiting
350 participants
Started: Apr 16, 2024 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT05132244
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
NA
Recruiting
50 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2027
3 conditions
4 sponsors
2 locations
NCT06253611
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
PHASE2
Recruiting
120 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2029
1 condition
1 sponsor
37 locations
NCT06254066
Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
PHASE2
Not yet recruiting
40 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2028
3 conditions
2 sponsors
0 locations
NCT06093464
Beneficial Exposome Study
NA
Recruiting
40 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT06453668
A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
PHASE1
Active, not recruiting
48 participants
Started: Apr 16, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
3 locations
NCT06365671
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
PHASE2
Recruiting
16 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT06372145
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
PHASE3
Recruiting
2,500 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2029
3 conditions
1 sponsor
349 locations
NCT06224816
Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants
NA
Recruiting
60 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06373393
SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique
N/A
Enrolling by invitation
50 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2024
2 conditions
3 sponsors
1 location
NCT05219175
MDMA for Co-occurring PTSD and OUD After Childbirth
PHASE2
Recruiting
15 participants
Started: Apr 16, 2024 · Completed: Nov 30, 2027
2 conditions
2 sponsors
1 location
NCT06808295
Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients
PHASE1
Recruiting
24 participants
Started: Apr 16, 2024 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT06397703
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
PHASE2
Recruiting
392 participants
Started: Apr 16, 2024 · Completed: Apr 16, 2031
1 condition
1 sponsor
1 location
NCT06202196
Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy
NA
Recruiting
74 participants
Started: Apr 16, 2024 · Completed: Apr 16, 2028
1 condition
1 sponsor
1 location
NCT06155500
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
PHASE1
Active, not recruiting
4 participants
Started: Apr 16, 2024 · Completed: Jan 11, 2039
1 condition
1 sponsor
3 locations
NCT06372496
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
PHASE4
Active, not recruiting
1,357 participants
Started: Apr 16, 2024 · Completed: Jan 22, 2026
1 condition
1 sponsor
74 locations
NCT06291363
Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.
PHASE4
Recruiting
64 participants
Started: Apr 16, 2024 · Completed: Mar 4, 2025
3 conditions
1 sponsor
1 location
NCT06044571
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
NA
Recruiting
180 participants
Started: Apr 16, 2024 · Completed: Sep 1, 2027
2 conditions
2 sponsors
1 location
NCT05663385
Mucograft Seal in ARP Follow-up
N/A
Recruiting
75 participants
Started: Apr 16, 2024 · Completed: Oct 1, 2025
1 condition
2 sponsors
1 location
NCT06375109
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
PHASE2
Not yet recruiting
60 participants
Started: Apr 16, 2024 · Completed: Apr 15, 2029
1 condition
1 sponsor
0 locations
NCT05908331
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NA
Recruiting
492 participants
Started: Apr 16, 2024 · Completed: Jul 31, 2028
3 conditions
2 sponsors
28 locations
NCT05951777
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
PHASE2
Recruiting
51 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT06043427
Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
PHASE2
Recruiting
168 participants
Started: Apr 16, 2024 · Completed: Jun 30, 2026
1 condition
2 sponsors
18 locations
NCT06392126
Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS
PHASE1/PHASE2
Active, not recruiting
1 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06377891
The Effect of Emotional Resilience Training on Fear of Birth and Depression in Primiparous Pregnant Women
NA
Enrolling by invitation
80 participants
Started: Apr 16, 2024 · Completed: Dec 30, 2024
2 conditions
1 sponsor
1 location
NCT06096038
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
PHASE1/PHASE2
Recruiting
33 participants
Started: Apr 16, 2024 · Completed: Aug 31, 2028
4 conditions
3 sponsors
1 location
NCT02998229
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
NA
Recruiting
220 participants
Started: Apr 16, 2024 · Completed: Feb 29, 2032
1 condition
1 sponsor
13 locations
NCT06192576
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
N/A
Recruiting
10 participants
Started: Apr 16, 2024 · Completed: Jan 15, 2029
2 conditions
2 sponsors
4 locations
NCT06014762
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
PHASE1
Recruiting
120 participants
Started: Apr 16, 2024 · Completed: Mar 31, 2041
10 conditions
2 sponsors
14 locations
NCT06178055
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
PHASE2
Active, not recruiting
75 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT06123715
Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty
PHASE2
Recruiting
300 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
3 conditions
3 sponsors
3 locations
NCT07211321
Linking Diet, Inflammation, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study
N/A
Recruiting
1,220 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06309069
Calcified Cerebral Embolism: a Descriptive Study in a Large Single Center Cohort
N/A
Recruiting
79 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT06240013
Acute Effects of Foam Rolling and Proprioceptive Neuromuscular Facilitation Stretching
NA
Recruiting
80 participants
Started: Apr 16, 2024 · Completed: Feb 28, 2025
1 condition
2 sponsors
1 location
NCT06207656
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
PHASE2
Recruiting
70 participants
Started: Apr 16, 2024 · Completed: Apr 1, 2029
1 condition
3 sponsors
1 location
NCT06368128
Climbing Lifestyle Intervention for Modifying Physical Activity Behaviors: Pilot Study
NA
Recruiting
12 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT06200155
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
PHASE2
Recruiting
30 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
Previous
1
More pages
1045
1046
1047
1048
1049
1050
1051
More pages
2369
Next